Urology · Los Angeles, CA
NPI
1114109626
Since 2007
Specialty
Urology
Code 208800000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
617 W. Manchester Blvd.
Los Angeles, CA, 90044
Phone (213) 375-4944
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
1,360 services
Medicare patients, 2024
204
Average age 68
Drug cost, 2024
$285K
1,276 prescriptions
Company payments, 2025
$82.15
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dana N Scott was code 99214 (office e&m - established), 391 times for 146 patients. In total Dana N Scott billed 1,360 services in 34 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 391 | 146 | $93.96 | $37K |
| G2010 Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within t | Office | 326 | 137 | $8.32 | $2,712 |
| 51741 Test - Miscellaneous | Office | 238 | 118 | $9.98 | $2,374 |
| 76857 Ultrasound - Abdomen and Pelvis | Office | 198 | 119 | $37.16 | $7,357 |
| 99204 Office E&M - New | Office | 59 | 59 | $112.97 | $6,665 |
| 99215 Office E&M - Established | Office | 48 | 35 | $137.16 | $6,584 |
| 52000 Cystourethroscopy | Office | 24 | 23 | $211.02 | $5,064 |
By year: 2022 $80K for 1,499 services; 2023 $102K for 1,781 services; 2024 $76K for 1,360 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dana N Scott prescribed most often to Medicare patients was Terazosin Hcl, with 420 prescriptions and refills. In total Dana N Scott wrote 1,276 Medicare prescriptions that cost $285K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Terazosin Hcl Generic | 420 | 929 | 186 | $6,048 |
| Tamsulosin Hcl Generic | 154 | 357 | 100 | $1,638 |
| Oxybutynin Chloride Generic | 130 | 187 | 97 | $1,376 |
| Tolterodine Tartrate Generic | 91 | 172 | 54 | $5,715 |
| Ciprofloxacin Hcl Generic | 79 | 79 | 68 | $338 |
| Gemtesa Vibegron | 73 | 127 | 36 | $60K |
| Myrbetriq Mirabegron | 47 | 79 | 29 | $35K |
| Doxazosin Mesylate Generic | 37 | 85 | 17 | $497 |
| Bicalutamide Generic | 31 | 79 | 15 | $1,216 |
| Imipramine Hcl Generic | 31 | 68 | 17 | $363 |
| Ibuprofen Generic | 21 | 24 | 18 | $142 |
| Bethanechol Chloride Generic | 19 | 27 | 11 | $820 |
| Lupron Depot Leuprolide Acetate | 18 | 69 | 11 | $132K |
| Finasteride Generic | 16 | 43 | Under 11 | $225 |
| Solifenacin Succinate Generic | 13 | 25 | Under 11 | $594 |
Brand drugs: 168 claims; generic drugs: 1,108 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dana N Scott $82.15 ($82.15 in general payments such as food, travel and fees) from 3 companies. The largest payer was Medtronic, Inc. with $34.35.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.